Exane Derivatives’s Ameresco AMRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-885
Closed -$70.4K 784
2022
Q1
$70.4K Sell
885
-602
-40% -$38K 0.02% 520
2021
Q4
$121K Sell
1,487
-3,215
-68% -$257K 0.03% 424
2021
Q3
$275K Sell
4,702
-5,568
-54% -$367K 0.07% 309
2021
Q2
$664K Buy
10,270
+8,772
+586% +$472K 0.15% 136
2021
Q1
$72.8K Buy
1,498
+194
+15% +$10.7K 0.02% 471
2020
Q4
$68.1K Buy
1,304
+513
+65% +$22.1K 0.02% 433
2020
Q3
$26.4K Buy
+791
New +$23.9K 0.01% 412

Other funds holding AMRC

Exane Derivatives's AMRC Position: Q2 2022 in Review

Exane Derivatives sold out of Ameresco (AMRC) in Q2 2022, closing a stake of 885 shares — an estimated $70.4K sold.

Exane Derivatives first reported a position in AMRC in Q3 2020 and held it in 7 quarters. The position peaked at $664K in Q2 2021. 214 funds tracked by Wall St. Rank hold AMRC as of Q2 2022.

  • Exane Derivatives reported no remaining Ameresco position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 885 Ameresco shares in Q2 2022, an estimated $70.4K.
  • Exane Derivatives first reported a position in Ameresco in Q3 2020 and held it in 7 quarters.
  • Exane Derivatives's Ameresco position peaked at $664K in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Ameresco as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.